Cargando…
Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer
BACKGROUND: The human leukocyte antigen class I (HLA-I) genotype has been linked with differential immune responses to infectious disease and cancer. However, the clinical relevance of germline HLA-mediated immunity in gastrointestinal (GI) cancer remains elusive. METHODS: This study retrospectively...
Autores principales: | Lu, Zhihao, Chen, Huan, Jiao, Xi, Wang, Yujiao, Wu, Lijia, Sun, Huaibo, Li, Shuang, Gong, Jifang, Li, Jian, Zou, Jianling, Yang, Keyan, Hu, Ying, Mao, Beibei, Zhang, Lei, Zhang, Xiaotian, Peng, Zhi, Lu, Ming, Wang, Zhenghang, Zhang, Henghui, Shen, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567649/ https://www.ncbi.nlm.nih.gov/pubmed/34732240 http://dx.doi.org/10.1186/s13073-021-00997-6 |
Ejemplares similares
-
Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer
por: Lu, Zhihao, et al.
Publicado: (2020) -
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
por: Wang, Yujiao, et al.
Publicado: (2022) -
Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer
por: Lu, Zhihao, et al.
Publicado: (2019) -
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients
por: Wang, Yanni, et al.
Publicado: (2021) -
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers
por: Wang, Yanni, et al.
Publicado: (2022)